Medixall Group, Inc. (MDXL) Stock Price & Analysis
Medixall Group, Inc. (MDXL) — price $0.0033 (0.00%), as of the Oct 5, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Medixall Group, Inc. · MDXL
MediXall Group, Inc. operates a healthcare marketplace platform aimed at enhancing consumer engagement in healthcare decisions. The company focuses on providing medical and wellness services through its Health Karma platform, targeting individuals and employer groups.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0033 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0001 – $0.0056 | |
| Shares traded on the day | 300 |
Price & events
Other perspectives
Council score for Medixall Group (MDXL): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 5, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the MDXL film — every key number, told as a short cinematic story
~2 min · open the film
What is Medixall Group (MDXL), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Medixall Group, Inc. (MDXL) is the company analyzed here. It employs 7 people and is led by Travis Jackson. In Q3 FY2024 it reported revenue of $38,858 and net income of $263,813.
What do the latest results show for Medixall Group (MDXL)?
Short answer · as of
The most recent reported quarter, Q3 FY2024, carried revenue of $38,858.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2024 | $38,858 | $263,813 | $0.0016 (diluted) |
| Q2 FY2024 | $52,839 | -$485,862 | -$0.0035 (diluted) |
| Q1 FY2024 | $118,142 | -$486,600 | -$0.0036 (diluted) |
What are the financial strengths and risks for Medixall Group (MDXL)?
Short answer
The distress and quality screens read Piotroski F 4. Trailing ratios: ROE 89.5% · current ratio 0.00.
Medixall Group Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the MDXL research dossier (written Jun 14, 2026 by gpt-4o-mini). Figures in this section are not part of the source register.
What does MediXall Group, Inc. do?
MediXall Group, Inc. operates a healthcare marketplace platform called Health Karma, which facilitates consumer engagement in healthcare decisions. The platform provides access to medical and wellness services, allowing users to learn about, decide on, and pay for healthcare in a transparent manner.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (12 figures)
The 12 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 7 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $0.0033 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T18:24:48.316Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 300 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q3 FY2024 | $38,858 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q3 FY2024 | $263,813 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 3 quarters through Q3 FY2024 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 5 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $0.0001 – $0.0056 | UNRECORDED | Stored company-profile observation — Captured 2026-10-02 | |
id.employees | Employees | 7 | UNRECORDED | Stored company-profile observation — Captured 2026-10-02 | |
id.ceo | Chief executive | Travis Jackson | UNRECORDED | Stored company-profile observation — Captured 2026-10-02 | |
fin.scores | Distress and quality screens | Piotroski F 4 | UNRECORDED | Stored financial-scores observation — Captured 2026-09-21 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 89.5% · current ratio 0.00 | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.